Solid Biosciences Announces Acquisition of AavantiBio and Concurrent $75 Million Private Placement

30.09.2022 - - Transactions to create a precision genetic medicine company focused on neuromuscular and cardiac rare diseases, led by industry veteran and current AavantiBio CEO, Bo Cumbo - - Strong synergies expected by combining key assets, including ...

Related Keywords

United States ,Cambridge ,Cambridgeshire ,United Kingdom ,Charlestown ,Cornwall ,Jessie Hanrahan ,Barry Byrne ,Scott Lessne ,Jenny Marlowe ,Stephen Dipalma ,Adam Koppel ,Caitlin Lowie ,Bo Cumbo ,Paul Herzich ,Roxana Donisa Dreghici ,Emanuela Corti ,Ilan Ganot ,Wilmer Cutler Pickering Hale ,Carl Morris ,Sidley Austin ,Bain Capital Life Sciences ,Care Center ,Perceptive Advisors ,Aavantibio Inc ,Companies To Host Conference Call ,Nasdaq ,Company Pipeline ,Exchange Commission ,Head Of Clinical Development ,University Of Florida Powell Gene Therapy Center ,Solid Biosciences Inc ,Uf Health ,Host Conference Call ,Solid Biosciences ,Chief Executive ,Capital Life Sciences ,Caas Capital Management ,Laurion Capital Management ,Pura Vida ,Chief Executive Officer ,Dilated Cardiomyopathy ,Undisclosed Cardiac ,Proposed Transactions ,Interim Chief Financial Officer ,Chief Scientific Officer ,Neuromuscular Diseases ,Cardiac Pipeline ,Clinical Development ,Chief Regulatory Officer ,Chief Technology Officer ,Chief Administrative ,Securities Act ,Cutler Pickering Hale ,Investor Relations ,Powell Gene Therapy Center ,Private Securities Litigation Reform Act ,Nasdaq Stock Market ,Nasdaq Global Select Market ,Additional Information Will Be Filed ,Media Contact ,Bio Media Contact ,